Pathogens Enzyme-Based Anthrax Therapy Shows Promise in Preclinical TrialsGlobal Biodefense StaffJune 17, 2025
Medical Countermeasures Novel Oral Chitosan-Based Compound Shows Promise for Radiological Emergency ResponseGlobal Biodefense StaffJune 12, 2025
Medical Countermeasures Single-Dose VSV Vaccine Fully Protects Mice Against Crimean-Congo Hemorrhagic FeverGlobal Biodefense StaffJune 5, 2025
AstraZeneca and Broad Institute Partner To Advance Antibacterials and Antivirals Antimicrobial Resistance September 17, 2012 …
FDA Grants Priority Review for Multi-Drug Resistant Tuberculosis Treatment Medical Countermeasures September 6, 2012 …
Biodefense BAA Supports Adjuvant Development for Emerging Diseases Contracts + Grants August 16, 2012 …
InBios, UN-Reno Partner to Develop Diagnostic for Melioidosis Medical Countermeasures August 9, 2012 …
DARPA Program Hits Milestone in Plant-Based Vaccines for Pandemics Medical Countermeasures July 28, 2012 …
UW Institute for Translational Health Sciences Receives $65M NIH Award Contracts + Grants July 23, 2012 …
